“Researchers have leveraged artificial intelligence methods to significantly speed up the discovery of treatments for Parkinson’s disease.

The researchers, from the University of Cambridge, designed and used an AI-based strategy to identify compounds that block the clumping, or aggregation, of alpha-synuclein, the protein that characterizes Parkinson’s.

The team used machine learning techniques to quickly screen a chemical library containing millions of entries and identified five highly potent compounds for further investigation.”

From SciTechDaily.